Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PcoMed is a private U.S. medical device surface technology company focused on proprietary surface modifications and coatings for implantable medical devices. The company appears to provide commercially used surface-engineering solutions intended to improve osseointegration, reduce implant-associated infection and biofilm formation, and enhance anti-thrombogenic performance in high-flow applications such as catheters. Publicly available descriptions reference technologies including TruBon for bone cell attachment and MicroBLOX for antimicrobial performance, as well as polymer-free elution of drugs or growth factors on device surfaces. PcoMed has supplied surface-modified implant products for FDA-cleared devices and has partnered with medical device developers rather than operating a traditional therapeutic drug pipeline. Overall, it is better characterized as a commercial medtech platform and services business than as a biotech or pharma drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PcoMed.